Compliance Rate

Compliance Rate 48.0%
Compliant submissions 48
Incompliant submissions 52
Total trials 100

Your Clinical Trials

Showing 541825 of 542236 entries
View as:

Near Infrared Fluorescence Imaging for Bladder Cancer Detection

Phase: N/A Priority: Normal
NCT ID: NCT03058705 Org: User:
Start: 11/28/17 End: 07/25/18 Due: 07/25/19

Chronic Hepatitis B and C Recall Northern Holland

Phase: N/A Priority: Normal
NCT ID: NCT02687061 Org: User:
Start: 02/29/16 End: 12/31/16 Due: 12/31/17

Tablet-Aided BehavioraL Intervention EffecT on Self-management Skills

Phase: N/A Priority: Normal
NCT ID: NCT02128854 Org: User:
Start: 08/14/14 End: 08/31/16 Due: 08/31/17

COVID-19 Stroke Apical Lung Examination Study

Phase: N/A Priority: Normal
NCT ID: NCT04640428 Org: User:
Start: 07/10/20 End: 10/31/21 Due: 10/31/22

Screening for Arteriopathy in General Medicine: a Preliminary Feasibility Study

Phase: N/A Priority: Normal
NCT ID: NCT02037178 Org: User:
Start: 10/28/14 End: 12/20/17 Due: 12/20/18

Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe Trauma

Phase: N/A Priority: Normal
NCT ID: NCT03368092 Org: User:
Start: 03/04/19 End: 12/01/27 Due: 12/01/28

A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04526899 Org: User:
Start: 05/19/21 End: 12/31/25 Due: 12/31/26

EMBRACE: Exercising Together

Phase: N/A Priority: Normal
NCT ID: NCT06049355 Org: User:
Start: 04/18/24 End: 09/01/28 Due: 09/01/29

Β3-adrenoreceptor As Prognostic Marker in Neuroblastoma and Ewing Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT06851221 Org: User:
Start: 08/05/20 End: 03/05/24 Due: 03/05/25

BCAAs, Muscle Protein Synthesis and Glucose Uptake

Phase: N/A Priority: Normal
NCT ID: NCT06218264 Org: User:
Start: 01/10/24 End: 12/31/25 Due: 12/31/26

ISB With SSNB & ANB

Phase: N/A Priority: Normal
NCT ID: NCT06878391 Org: User:
Start: 03/24/25 End: 01/31/27 Due: 01/31/28

Efficacy and Safety of Discontinuing 5-ASA in Patients With Inflammatory Bowel Disease

Phase: N/A Priority: Normal
NCT ID: NCT06878495 Org: User:
Start: 06/15/25 End: 12/31/25 Due: 12/31/26

Mucosal Associated Invariant T Cell During Viral Pneumonia and Acute Respiratory Distress Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT06720818 Org: User:
Start: 05/05/25 End: 02/28/29 Due: 02/28/30

Exploring the Olfactory Mucosa, Blood and Urine for the Identification of Early Biomarkers of Parkinson's Disease, Atypical Parkinsonisms and Neurocognitive Disorders Due to Lewy Body Disease

Phase: N/A Priority: Normal
NCT ID: NCT06846658 Org: User:
Start: 10/03/23 End: 04/30/26 Due: 04/30/27

A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.

Phase: N/A Priority: Normal
NCT ID: NCT06703606 Org: User:
Start: 05/13/25 End: 05/23/31 Due: 05/23/32

Switching of Sildenafil to Riociguat in CTEPH Patients

Phase: N/A Priority: Normal
NCT ID: NCT06715280 Org: User:
Start: 07/25/24 End: 01/22/27 Due: 01/22/28

Influenza a (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP)

Phase: N/A Priority: Normal
NCT ID: NCT06417853 Org: User:
Start: 07/31/24 End: 05/31/26 Due: 05/31/27

A Study to Evaluate Single Subcutaneous Doses of NXT007 Among Injection Sites Abdomen, Upper Arm, and Thigh in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT06189508 Org: User:
Start: 02/14/24 End: 12/22/24 Due: 12/22/25

A Study of Lung Cancer Screening in People With Unexplained Weight Loss

Phase: N/A Priority: Normal
NCT ID: NCT06717334 Org: User:
Start: 12/02/24 End: 12/31/26 Due: 12/31/27

Vemurafenib and White Blood Cell Therapy for Advanced Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01585415 Org: User:
Start: 04/09/12 End: 07/21/16 Due: 07/21/17

Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Vasculopathy (MONDEGO)

Phase: N/A Priority: Normal
NCT ID: NCT06709339 Org: User:
Start: 06/30/25 End: 04/30/28 Due: 04/30/29

Prediction of the Risk of Placental Vascular Pathology and Venous Thromboembolic Disease

Phase: N/A Priority: Normal
NCT ID: NCT00695942 Org: User:
Start: 06/30/08 End: 05/31/12 Due: 05/31/13

Metabolic Flexibility to Predict Lifestyle Interventions Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT06329349 Org: User:
Start: 01/02/24 End: 04/01/26 Due: 04/01/27

Does Rehabilitation After Total Hip or Knee Arthroplasty Work (DRAW2)

Phase: N/A Priority: Normal
NCT ID: NCT04960241 Org: User:
Start: 04/06/21 End: 03/22/25 Due: 03/22/26

VALOR: Vaginal Atrophy & Long-term Observation of Recovery

Phase: N/A Priority: Normal
NCT ID: NCT05953090 Org: User:
Start: 10/30/23 End: 12/31/26 Due: 12/31/27